98%
921
2 minutes
20
Background: Heart failure (HF) is a common disease globally. Ventricular assist devices (VADs) are widely used to treat HF. In contrast to the natural heart, different VADs generate different blood flow waves in the aorta.
Objective: To explore whether the different inflow rate waveforms from the ascending aorta generate far-reaching hemodynamic influences on the human aortic arch.
Methods: An aortic geometric model was reconstructed based on computed tomography data of a patient with HF. A total of five numerical simulations were conducted, including a case with the inflow rate waveforms from the ascending aorta with normal physiological conditions, two HF, and two with typical VAD support. The hemodynamic parameters, wall shear stress (WSS), oscillatory shear index (OSI), relative residence time (RRT), and the strength of the helical flow, were calculated.
Results: In contrast to the natural heart, numerical simulations showed that HF decreased WSS and induced higher OSI and RRT. Moreover, HF weakened helical flow strength. Pulsatile flow VADs that elevated the WSS, induced some helical flow, while continuous flow VADs could not.
Conclusions: HF leads to an adverse hemodynamic environment by decreasing WSS and reducing the helical flow strength. Based upon hemodynamic effects, pulsatile flow VADs may be more advantageous than continuous flow VADs. Thus, pulsatile flow VADs may be a better option for patients with HF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/BIR-201009 | DOI Listing |
Artif Organs
August 2025
Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
Background: Computational fluid dynamics (CFD) has become an essential design tool for ventricular assist devices (VADs), where the goal of maximizing performance often conflicts with biocompatibility. This tradeoff becomes even more pronounced in pediatric applications due to the stringent size constraints imposed by the smaller patient population. This study presents an automated CFD-driven shape optimization of a new intermediate diffuser stage for the PediaFlow pediatric VAD, positioned immediately downstream of the impeller to improve pressure recovery.
View Article and Find Full Text PDFArXiv
July 2025
Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Background: Computational fluid dynamics (CFD) has become an essential design tool for ventricular assist devices (VADs), where the goal of maximizing performance often conflicts with biocompatibility. This tradeoff becomes even more pronounced in pediatric applications due to the stringent size constraints imposed by the smaller patient population. This study presents an automated CFD-driven shape optimization of a new intermediate diffuser stage for the PediaFlow pediatric VAD, positioned immediately downstream of the impeller to improve pressure recovery.
View Article and Find Full Text PDFJ Biomech Eng
September 2025
Industrial and Health Science and Technology Research Center (STIS), ENSAM, Mohammed V University in Rabat, Rabat 10110, Morocco.
The design and optimization of ventricular assist devices (VADs) are critical for improving their hydraulic performance and clinical outcomes. This study employs computational modeling, feature importance analysis, and response surface optimization to enhance the performance of a VAD rotor. A three-dimensional, steady-state, incompressible flow model was used to simulate blood flow, with blood modeled as a Newtonian fluid.
View Article and Find Full Text PDFCardiovasc Eng Technol
June 2025
Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.
Purpose: Ventricular assist devices (VADs) are most often computationally evaluated as isolated devices subjected to idealized steady-state blood flow conditions. In clinical practice, these devices are connected to, or within, diseased pulsatile ventricles of the heart, which can dramatically affect the hemodynamics, hence hemocompatibility-related adverse events such as hemolysis, bleeding, and thrombosis. Therefore, improved simulations are needed to more realistically represent the coupling of devices to the assisted ventricle.
View Article and Find Full Text PDFBiochem Biophys Rep
September 2025
INTEGRIS Advanced Cardiopulmonary Care, INTEGRIS Baptist Medical Center, 3400 NW Expressway, Ste 200, Oklahoma City, OK 73112, USA.
Implantations of Ventricular Assist Devices (VADs) have significantly improved quality of life and life expectancy of end-stage heart failure patients. However, despite the advancements in the VAD designs and patient management protocols, the VAD recipients remain at risk of attaining bleeding, infection, pump thrombosis, and stroke. Although blood trauma has been suggested as a critical factor in development of these adverse events, its consequences in inducing interactions between different types of blood cells are largely unknown.
View Article and Find Full Text PDF